Reported covered position: Staff Assistant/Clerk - House Ways and Means 2014; Legislative Director - Rep. Mike Bishop 2015-2018
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: U.S. VENTURE, INC. (FORMERLY U.S. OIL) · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUNIVA, INC. · Firm: MAYER BROWN LLP
Issues related to HR 1 (One Big Beautiful Bill Act).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ONSEMI (ON SEMICONDUCTOR CORPORATION) via MAYER BROWN LLP
2026 · third_quarter · Q3
Monitor and outreach on issues related to energy consumption of AI data centers.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
WAUPACA FOUNDRY, INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Source: Senate LDA
| PRIMEMAX MEDICAL INDUSTRIES, INC. |
| 5 |
| 2025–2026 |
| STARR INSURANCE HOLDINGS, INC. | 5 | 2025–2026 |
| ELEMENT ELECTRONICS | 4 | 2025–2026 |
| SUNIVA, INC. | 4 | 2025–2026 |
| SYENSQO USA LLC | 4 | 2025–2026 |
| U.S. VENTURE, INC. (FORMERLY U.S. OIL) | 4 | 2025–2026 |
| PENN ALUMINUM INTERNATIONAL LLC | 3 | 2026 |
| SOLONIAN RESOURCES, LLC | 3 | 2025–2026 |
| IFM INVESTORS PTY LTD. | 2 | 2026 |
| ONSEMI (ON SEMICONDUCTOR CORPORATION) | 2 | 2026 |
| UNITED STATES STEEL CORPORATION | 2 | 2025 |
| WAUPACA FOUNDRY, INC. | 2 | 2026 |
| Rabo AgriFinance LLC | 1 | 2025 |
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: RABO AGRIFINANCE LLC · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: U.S. VENTURE, INC. (FORMERLY U.S. OIL) · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GALAXY DIGITAL HOLDINGS, LP · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act) implementation.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: U.S. VENTURE, INC. (FORMERLY U.S. OIL) · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: U.S. VENTURE, INC. (FORMERLY U.S. OIL) · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GALAXY DIGITAL HOLDINGS, LP · Firm: MAYER BROWN LLP
Issues related to One Big Beautiful Bill Act (H.R.1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SUNIVA, INC. · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GALAXY DIGITAL HOLDINGS, LP · Firm: MAYER BROWN LLP
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Issues related to USMCA negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PENN ALUMINUM INTERNATIONAL LLC via MAYER BROWN LLP
2026 · third_quarter · 3A
Issues related to 232 and 301 tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PENN ALUMINUM INTERNATIONAL LLC via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to 232 and 301 tariffs.
Issues related to Section 232 and 301 tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLONIAN RESOURCES, LLC via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to trade and tariff policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to Section 232 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to implementation of the One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STARR INSURANCE HOLDINGS, INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to Department of Labor claims processing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
PRIMEMAX MEDICAL INDUSTRIES, INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to trade and tariff policy.
Filing targets: Commerce, Dept of (DOC), U.S. Trade Representative (USTR)
2026 · third_quarter · Q3
Issues related to Section 232 investigations.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
IFM INVESTORS PTY LTD. via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to infrastructure policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEMENT ELECTRONICS via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to Section 232 and Section 301 tariffs and review of the USMCA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OURARING INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Issues related to wearables and health technology.
Issues relating to wearables and health technology.
Issues related to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2026 · third_quarter · Q3
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
WAUPACA FOUNDRY, INC. via MAYER BROWN LLP
2026 · third_quarter · RR
Issues related to trade policy, tariffs, and supply chain regulations affecting U.S. iron casting manufacturers and their customers in the automotive, commercial vehicle, agricultural, and industrial sectors.
PENN ALUMINUM INTERNATIONAL LLC via MAYER BROWN LLP
2026 · third_quarter · RR
Issues related to 232 and 301 tariffs.
ONSEMI (ON SEMICONDUCTOR CORPORATION) via MAYER BROWN LLP
2026 · second_quarter · 2A
Monitor and outreach on issues related to energy consumption of AI data centers.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
STARR INSURANCE HOLDINGS, INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to Department of Labor claims processing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SUNIVA, INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
General issues relating to Section 232 National Security Investigation of Polysilicon and its Derivates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IFM INVESTORS PTY LTD. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to infrastructure policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
OURARING INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to wearables and health technology.
Issues relating to wearables and health technology.
Issues related to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMEMAX MEDICAL INDUSTRIES, INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to trade and tariff policy.
Filing targets: Commerce, Dept of (DOC), U.S. Trade Representative (USTR)
2026 · second_quarter · Q2
Issues related to Section 232 investigations.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to Section 232 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ITO EN (NORTH AMERICA) INC. via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to Section 232 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEMENT ELECTRONICS via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to tariffs and trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2026 · second_quarter · Q2
Issues related to implementation of the One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. VENTURE, INC. (FORMERLY U.S. OIL) via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
STARR INSURANCE HOLDINGS, INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to Department of Labor claims processing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SYENSQO USA LLC via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to trade and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SUNIVA, INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
General issues relating to Section 232 National Security Investigation of Polysilicon and its Derivates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLONIAN RESOURCES, LLC via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to trade and tariff policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PRIMEMAX MEDICAL INDUSTRIES, INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to trade and tariff policy.
Filing targets: Commerce, Dept of (DOC), U.S. Trade Representative (USTR)
OURARING INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to wearables and health technology.
Issues related to wearables and health technology.
Issues relating to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to trade and tariff policy.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to Section 232 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ITO EN (NORTH AMERICA) INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to Section 232 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2026 · first_quarter · Q1
Issues related to implementation of the One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2026 · first_quarter · Q1
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues related to trade and tariff policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2025 · fourth_quarter · RR
General issues pertaining to Section 301 investigations.
General issues pertaining to Section 301 investigations.
SOLONIAN RESOURCES, LLC via MAYER BROWN LLP
2025 · fourth_quarter · RR
General issues related to ferrochrome.
SYENSQO USA LLC via MAYER BROWN LLP
2025 · fourth_quarter · 4A
Issues related to trade and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SUNIVA, INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Issues related to trade and tariff policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMEMAX MEDICAL INDUSTRIES, INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to trade and tariff policy.
Filing targets: Commerce, Dept of (DOC), U.S. Trade Representative (USTR)
SYENSQO USA LLC via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to trade and tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STARR INSURANCE HOLDINGS, INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to Department of Labor claims processing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
U.S. VENTURE, INC. (FORMERLY U.S. OIL) via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
OURARING INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues relating to wearables and health technology.
Issues related to wearables and health technology.
Issues related to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ITO EN (NORTH AMERICA) INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to tariff and trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to tariff and trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
ELEMENT ELECTRONICS via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to USMCA review.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2025 · fourth_quarter · Q4
Issues related to implementation of the One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYENSQO USA LLC via MAYER BROWN LLP
2025 · fourth_quarter · RR
General issues related to Investigation 337-1439 Certain Polyvinylidene Fluoride Resins.
PRIMEMAX MEDICAL INDUSTRIES, INC. via MAYER BROWN LLP
2025 · fourth_quarter · RR
Issues related to tariffs.
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES STEEL CORPORATION via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to tariff and trade negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to Sec. 232 investigations and tariff policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ITO EN (NORTH AMERICA) INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to US-Japan trade negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STARR INSURANCE HOLDINGS, INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to Department of Labor claims processing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SUNIVA, INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to HR 1 (One Big Beautiful Bill Act).
Issues related to tariff negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. VENTURE, INC. (FORMERLY U.S. OIL) via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
OURARING INC. via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues relating to wearables and health technology.
Issues related to wearables and health technology.
Issues related to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEMENT ELECTRONICS via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to the Miscellaneous Tariff Bill.
Issues related to tariffs and trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ITO EN (NORTH AMERICA) INC. via MAYER BROWN LLP
2025 · third_quarter · RR
General issues related to Section 232 investigations.
MICHELIN NORTH AMERICA, INC. via MAYER BROWN LLP
2025 · third_quarter · RR
General issues related to Section 232 investigations.
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2025 · third_quarter · Q3
Issues related to H.R. 1 (One Big Beautiful Bill Act) implementation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. VENTURE, INC. (FORMERLY U.S. OIL) via MAYER BROWN LLP
2025 · second_quarter · Q2
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
UNITED STATES STEEL CORPORATION via MAYER BROWN LLP
2025 · second_quarter · Q2
Issues related to the proposed investment in U. S. Steel by Nippon Steel Corporation, including necessary federal regulatory reviews (Anti-trust, CFIUS) - no specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RABO AGRIFINANCE LLC via MAYER BROWN LLP
2025 · second_quarter · Q2
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OURARING INC. via MAYER BROWN LLP
2025 · second_quarter · Q2
Issues relating to wearables and health technology.
Issues related to wearables and health technology.
Issues related to wearables and health technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2025 · second_quarter · Q2
Issues related to H.R. 1 (One Big Beautiful Bill Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR REGULATED HFCS INC. via MAYER BROWN LLP
2025 · second_quarter · Q2
Implementation of the American Innovation and Manufacturing Act and trade in HFCs.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
GALAXY DIGITAL HOLDINGS, LP via MAYER BROWN LLP
2025 · second_quarter · RR
Issues related to One Big Beautiful Bill Act (H.R.1).
OURARING INC. via MAYER BROWN LLP
2025 · second_quarter · RR
General issues relating to wearables and health technology.
General issues relating to wearables and health technology.
General issues relating to wearables and health technology.